Dana Razzano is a PGY-5 Cytopathology Fellow at Yale School of Medicine and future GI/Pancreas/Liver Fellow at Stanford (2021-2022). She was named by The Pathologist’s Power List in 2018 as one of “100 of the best, brightest, and most powerful advocates of pathology” and was recognized again on the 2019 Power List as one of “100 of the industry’s top trailblazers.” She was also awarded the American Society of Clinical Pathology’s 2018 Top 5, 40 under Forty distinction for “achievements and leadership qualities that are making an impact on pathology and laboratory medicine.” Her career goals are to contribute solutions to the challenges faced by low resource laboratories nationally and internationally.
